相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis
Darren K. McGuire et al.
JAMA CARDIOLOGY (2021)
2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
Kyu Yeon Hur et al.
DIABETES & METABOLISM JOURNAL (2021)
Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000-2019
Kyung Ae Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
Lars Johansson et al.
DIABETES OBESITY & METABOLISM (2020)
Body Fat Percentage Rather than Body Mass Index Related to the High Occurrence of Type 2 Diabetes
Jorge Escobedo-de la Pena et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
Xiruo Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Use and effectiveness of dapagliflozin in patients with type 2 diabetes mellitus: a multicenter retrospective study in Taiwan
Jung-Fu Chen et al.
PEERJ (2020)
Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease
Ju-Young Hong et al.
JOURNAL OF OBESITY & METABOLIC SYNDROME (2020)
Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study
Takashi Sasaki et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice
A. Ram Hong et al.
DIABETES & METABOLISM JOURNAL (2019)
Association between Body Fat and Diabetic Peripheral Neuropathy in Middle-Aged Adults with Type 2 Diabetes Mellitus: A Preliminary Report
Tae Jung Oh et al.
JOURNAL OF OBESITY & METABOLIC SYNDROME (2019)
Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status
Bo-Yeon Kim et al.
DIABETES & METABOLISM JOURNAL (2019)
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Dirk Mueller-Wieland et al.
DIABETES OBESITY & METABOLISM (2018)
Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes
Seigo Sugiyama et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Effect of Tofogliflozin on Body Composition and Glycemic Control In Japanese Subjects with Type 2 Diabetes Mellitus
Shinji Kamei et al.
JOURNAL OF DIABETES RESEARCH (2018)
Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials
Serge Jabbour et al.
DIABETES OBESITY & METABOLISM (2018)
Real-world effectiveness and safety of dapagliflozin therapy added to a GLP1 receptor agonist in patients with type 2 diabetes
J. J. Gorgojo-Martinez et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)
Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
Seung-Hyun Ko et al.
DIABETES & METABOLISM JOURNAL (2017)
Visceral Fat Mass Has Stronger Associations with Diabetes and Prediabetes than Other Anthropometric Obesity Indicators among Korean Adults
Suk Hwa Jung et al.
YONSEI MEDICAL JOURNAL (2016)
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
J. Bolinder et al.
DIABETES OBESITY & METABOLISM (2014)
2014 Clinical Practice Guidelines for Overweight and Obesity in Korea
Mee Kyoung Kim et al.
ENDOCRINOLOGY AND METABOLISM (2014)
Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States
Ronald C. W. Ma et al.
YEAR IN DIABETES AND OBESITY (2013)
Adiposopathy Is Sick Fat a Cardiovascular Disease?
Harold E. Bays
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index
U. Lim et al.
NUTRITION & DIABETES (2011)
Altered body composition in type 2 diabetes mellitus
S. Heshka et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes
M Fukushima et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
分享论文
